Attovia Therapeutics, Inc. (ATTO)
23.14
-0.52
(-2.20%)
USD |
NASDAQ |
Sep 09, 15:09
Attovia Therapeutics Market Cap : 1.056B for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.080B |
| September 04, 2026 | 1.166B |
| September 03, 2026 | 1.105B |
| September 02, 2026 | 1.056B |
| September 01, 2026 | 1.014B |
| August 31, 2026 | 976.94M |
| August 28, 2026 | 944.98M |
| August 27, 2026 | 923.40M |
| August 26, 2026 | 841.22M |
| August 25, 2026 | 830.89M |
| August 24, 2026 | 887.26M |
| August 21, 2026 | 895.00M |
| August 20, 2026 | 869.62M |
| Date | Value |
|---|---|
| August 19, 2026 | 952.66M |
| August 18, 2026 | 999.99M |
| August 17, 2026 | 977.19M |
| August 14, 2026 | 854.56M |
| August 13, 2026 | 825.30M |
| August 12, 2026 | 777.10M |
| August 11, 2026 | 802.49M |
| August 10, 2026 | 853.70M |
| August 07, 2026 | 867.89M |
| August 06, 2026 | 876.93M |
| August 05, 2026 | 942.34M |
| August 04, 2026 | 731.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 34.33B |
| Agenus, Inc. | 293.62M |
| Amgen, Inc. | 211.37B |
| Anika Therapeutics, Inc. | 279.84M |
| BioCryst Pharmaceuticals, Inc. | 2.311B |
Market Cap Related Metrics
| PS Ratio | 2347.49 |
| Price | 23.14 |
| Earnings Yield | -6.55% |